Press Release

Ajinomoto Genexine announced that it is attempting to become self-sufficient as a medium for cutting-edge 

biopharmaceuticals through the development of a serum-free chemical composition medium.

Ajinomoto Genexine is a company jointly established in 2012 by Ajinomoto and bio venture Genexine to develop and 

manufacture animal cell culture media and provide consignment production services. Local production of badges has been achieved.

In addition, through the CELLiST series, Ajinomoto Genexine is introducing cell culture media containing high-quality amino acid technology.

The serum-free chemical composition medium that Ajinomoto Genexine is developing to become self-sufficient as a medium for cutting-edge biopharmaceuticals does not contain animal-derived substances, ensuring high safety, and 

is easy to industrialize because the composition can be specified.

However, considering the fact that it is not easy to change from an existing badge to another, CELLiST has provided 

active support through the switch program to increase development and production efficiency.

CELLiST's switch program does not charge separate product development costs for changing badges, and supports 

experiments using various instruments such as ambr, HPLC, and UPLC owned by Ajinomoto Genexine. We also actively support document-related tasks such as equivalency approval and direct submission of composition to the licensing agency.

An official from the company said, “If the serum-free chemical composition medium succeeds in becoming 

self-sufficient as a medium for advanced biopharmaceuticals, it will facilitate the supply and demand of media for 

domestic pharmaceutical and bio companies and greatly contribute to the rapid localization of all processes.” “We ask 

for your interest in CELLiST’s switch program, which can supply the optimal badge to meet your needs.”